Naoto T Ueno

Naoto T Ueno

UNVERIFIED PROFILE

Are you Naoto T Ueno?   Register this Author

Register author
Naoto T Ueno

Naoto T Ueno

Publications by authors named "Naoto T Ueno"

Are you Naoto T Ueno?   Register this Author

100Publications

3248Reads

47Profile Views

Excellent Locoregional Control in Inflammatory Breast Cancer With a Personalized Radiation Therapy Approach.

Pract Radiat Oncol 2019 Nov 24;9(6):402-409. Epub 2019 May 24.

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.prro.2019.05.011DOI Listing
November 2019

Prediction of Bone Metastasis in Inflammatory Breast Cancer Using a Markov Chain Model.

Oncologist 2019 Oct 5;24(10):1322-1330. Epub 2019 Apr 5.

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

View Article

Download full-text PDF

Source
http://theoncologist.alphamedpress.org/lookup/doi/10.1634/th
Publisher Site
http://dx.doi.org/10.1634/theoncologist.2018-0713DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6795167PMC
October 2019

Bone Metastasis of Breast Cancer.

Adv Exp Med Biol 2019 ;1152:105-129

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-3-030-20301-6_7DOI Listing
September 2019

Comparison of molecular profile in triple-negative inflammatory and non-inflammatory breast cancer not of mesenchymal stem-like subtype.

PLoS One 2019 18;14(9):e0222336. Epub 2019 Sep 18.

Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0222336PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6750603PMC
September 2019

Elevated serum levels of sialyl Lewis X (sLe) and inflammatory mediators in patients with breast cancer.

Breast Cancer Res Treat 2019 Aug 3;176(3):545-556. Epub 2019 May 3.

Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, 1220 Holcombe Blvd, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-019-05258-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6653624PMC
August 2019

Correction to: Anti-tumor and anti-metastasis efficacy of E6201, a MEK1 inhibitor, in preclinical models of triple-negative breast cancer.

Breast Cancer Res Treat 2019 07;176(1):251

Section of Translational Breast Cancer Research, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030-4009, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-019-05218-8DOI Listing
July 2019

Anti-tumor and anti-metastasis efficacy of E6201, a MEK1 inhibitor, in preclinical models of triple-negative breast cancer.

Breast Cancer Res Treat 2019 Jun 2;175(2):339-351. Epub 2019 Mar 2.

Section of Translational Breast Cancer Research, Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-019-05166-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6534477PMC
June 2019

The impact of Ki-67 in the context of multidisciplinary care in primary inflammatory breast cancer.

J Cancer 2019 2;10(12):2635-2642. Epub 2019 Jun 2.

Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7150/jca.32453DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6584927PMC
June 2019

Imaging features of triple-negative breast cancers according to androgen receptor status.

Eur J Radiol 2019 May 21;114:167-174. Epub 2019 Mar 21.

Department of Diagnostic Radiology, Unit 1350, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejrad.2019.03.017DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481318PMC
May 2019

Eicosapentaenoic acid in combination with EPHA2 inhibition shows efficacy in preclinical models of triple-negative breast cancer by disrupting cellular cholesterol efflux.

Oncogene 2019 03 20;38(12):2135-2150. Epub 2018 Nov 20.

Section of Translational Breast Cancer Research and Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41388-018-0569-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6430703PMC
March 2019

Cooperative Effect of Oncogenic and in an HGF-Dominant Environment in Breast Cancer.

Mol Cancer Ther 2019 02 5;18(2):399-412. Epub 2018 Dec 5.

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-18-0710DOI Listing
February 2019

Author Correction: Landscape of somatic mutations in 560 breast cancer whole-genome sequences.

Nature 2019 02;566(7742):E1

Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/s41586-019-0883-2
Publisher Site
http://dx.doi.org/10.1038/s41586-019-0883-2DOI Listing
February 2019

ST8SIA1 Regulates Tumor Growth and Metastasis in TNBC by Activating the FAK-AKT-mTOR Signaling Pathway.

Mol Cancer Ther 2018 12 20;17(12):2689-2701. Epub 2018 Sep 20.

Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-18-0399DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6279518PMC
December 2018

The Emerging Impact of Social Media on Cancer Patient Education in Japan.

Oncologist 2018 09 22;23(9):e105-e106. Epub 2018 Mar 22.

Section of Translational Breast Cancer Research, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2017-0670DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6192603PMC
September 2018

Impact of change in body mass index during neoadjuvant chemotherapy and survival among breast cancer subtypes.

Breast Cancer Res Treat 2018 Sep 18;171(2):501-511. Epub 2018 Jun 18.

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe, Unit 1354, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-018-4853-4DOI Listing
September 2018

Inflammatory breast cancer biology: the tumour microenvironment is key.

Nat Rev Cancer 2018 08;18(8):485-499

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41568-018-0010-yDOI Listing
August 2018

Author Correction: Inflammatory breast cancer biology: the tumour microenvironment is key.

Nat Rev Cancer 2018 Aug;18(8):526

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41568-018-0022-7DOI Listing
August 2018

Inflammatory Breast Cancer: What to Know About This Unique, Aggressive Breast Cancer.

Surg Clin North Am 2018 Aug 24;98(4):787-800. Epub 2018 May 24.

Morgan Welch Inflammatory Breast Cancer Research and Clinic Program, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA; Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.suc.2018.03.009DOI Listing
August 2018

Decreased expression of microRNA-26b in locally advanced and inflammatory breast cancer.

Hum Pathol 2018 07 22;77:121-129. Epub 2018 Apr 22.

Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2018.04.002DOI Listing
July 2018

Low-dimensional dynamical characterization of human performance of cancer patients using motion data.

Clin Biomech (Bristol, Avon) 2018 07 18;56:61-69. Epub 2018 May 18.

Department of Aerospace & Mechanical Engineering, University of Southern California, Los Angeles, CA 90089, USA; Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA 90033, USA; Department of Mathematics, University of Southern California, Los Angeles, CA 90089, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clinbiomech.2018.05.007DOI Listing
July 2018

Preclinical and phase I clinical studies of KW-2450, a dual IGF-1R/IR tyrosine kinase inhibitor, in combination with lapatinib and letrozole.

Ther Adv Med Oncol 2018 30;10:1758835918786858. Epub 2018 Jul 30.

Section of Translational Breast Cancer Research, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1354, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1758835918786858DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6066809PMC
July 2018

Factors associated with improved outcomes for metastatic inflammatory breast cancer patients.

Breast Cancer Res Treat 2018 Jun 19;169(3):615-623. Epub 2018 Feb 19.

Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-018-4715-0DOI Listing
June 2018

Development of CNS metastases and survival in patients with inflammatory breast cancer.

Cancer 2018 06 26;124(11):2299-2305. Epub 2018 Mar 26.

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.31336DOI Listing
June 2018

Survivorship and Advocacy in Inflammatory Breast Cancer.

J Cancer 2018 6;9(8):1430-1436. Epub 2018 Apr 6.

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7150/jca.21281DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5929088PMC
April 2018

Prospective Feasibility Trial of Sentinel Lymph Node Biopsy in the Setting of Inflammatory Breast Cancer.

Clin Breast Cancer 2018 02 10;18(1):e73-e77. Epub 2017 Jul 10.

Department of Breast Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas M.D. Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clbc.2017.06.014DOI Listing
February 2018

BRCA mutations in women with inflammatory breast cancer.

Cancer 2018 02 17;124(3):466-474. Epub 2017 Oct 17.

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.31069DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5780239PMC
February 2018

Reply to Diagnosis of patients with inflammatory breast cancer is a problematic issue.

Cancer 2018 02 19;124(4):866. Epub 2017 Dec 19.

Department of Breast Medical Oncology; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.31188DOI Listing
February 2018

Prior systemic treatment increased the incidence of somatic mutations in metastatic breast cancer.

Eur J Cancer 2018 01 9;89:64-71. Epub 2017 Dec 9.

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2017.11.015DOI Listing
January 2018

Thrombocytosis as a prognostic factor in inflammatory breast cancer.

Breast Cancer Res Treat 2017 Dec 22;166(3):819-832. Epub 2017 Aug 22.

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, 1220 Holcombe Blvd, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10549-017-4463-6
Publisher Site
http://dx.doi.org/10.1007/s10549-017-4463-6DOI Listing
December 2017

Association between weight gain during adjuvant chemotherapy for early-stage breast cancer and survival outcomes.

Cancer Med 2017 Nov 10;6(11):2515-2522. Epub 2017 Oct 10.

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cam4.1207DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5673950PMC
November 2017

In response to "outcomes of patients with inflammatory breast cancer treated by breast conserving surgery": the argument against breast conservation and sentinel lymph node biopsy in IBC.

Breast Cancer Res Treat 2017 10 3;165(3):779-781. Epub 2017 Jul 3.

Department of Breast Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10549-017-4337-y
Publisher Site
http://dx.doi.org/10.1007/s10549-017-4337-yDOI Listing
October 2017

Improved Locoregional Control in a Contemporary Cohort of Nonmetastatic Inflammatory Breast Cancer Patients Undergoing Surgery.

Ann Surg Oncol 2017 Oct 1;24(10):2981-2988. Epub 2017 Aug 1.

Department of Breast Surgical Oncology, University of Texas, MD Anderson Cancer Center, 1400 Pressler Drive, Unit 1434, FCT 7.5046, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-017-5952-xDOI Listing
October 2017

Androgen Receptor Function and Androgen Receptor-Targeted Therapies in Breast Cancer: A Review.

JAMA Oncol 2017 Sep;3(9):1266-1273

Section of Translational Breast Cancer Research, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2016.4975DOI Listing
September 2017

Non-glycanated Decorin Is a Drug Target on Human Adipose Stromal Cells.

Mol Ther Oncolytics 2017 Sep 17;6:1-9. Epub 2017 May 17.

The Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.omto.2017.05.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5458115PMC
September 2017

Reverse phase protein array identification of triple-negative breast cancer subtypes and comparison with mRNA molecular subtypes.

Oncotarget 2017 Sep 31;8(41):70481-70495. Epub 2017 Jul 31.

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://www.oncotarget.com/fulltext/19719
Publisher Site
http://dx.doi.org/10.18632/oncotarget.19719DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5642571PMC
September 2017

Location of Receipt of Initial Treatment and Outcomes in Long-Term Breast Cancer Survivors.

PLoS One 2017 13;12(1):e0170081. Epub 2017 Jan 13.

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0170081PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5234813PMC
August 2017

Histone Deacetylase Inhibitor Enhances the Efficacy of MEK Inhibitor through NOXA-Mediated MCL1 Degradation in Triple-Negative and Inflammatory Breast Cancer.

Clin Cancer Res 2017 Aug 2;23(16):4780-4792. Epub 2017 May 2.

Section of Translational Breast Cancer Research, Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-16-2622DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5559319PMC
August 2017

MEK and PI3K catalytic activity as predictor of the response to molecularly targeted agents in triple-negative breast cancer.

Biochem Biophys Res Commun 2017 08 30;489(4):484-489. Epub 2017 May 30.

Graduate School of Life and Environmental Sciences, Osaka Prefecture University, 1-1 Gakuen-cho, Naka-ku, Sakai, Osaka 599-8531, Japan. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbrc.2017.05.177DOI Listing
August 2017

Selinexor (KPT-330) demonstrates anti-tumor efficacy in preclinical models of triple-negative breast cancer.

Breast Cancer Res 2017 Aug 15;19(1):93. Epub 2017 Aug 15.

Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13058-017-0878-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5557476PMC
August 2017

Poor prognosis of patients with triple-negative breast cancer can be stratified by RANK and RANKL dual expression.

Breast Cancer Res Treat 2017 Jul 17;164(1):57-67. Epub 2017 Apr 17.

Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10549-017-4233-5
Publisher Site
http://dx.doi.org/10.1007/s10549-017-4233-5DOI Listing
July 2017

Novel therapeutic strategies in the treatment of triple-negative breast cancer.

Ther Adv Med Oncol 2017 Jul 13;9(7):493-511. Epub 2017 Jun 13.

Department of Medical Oncology, The National Cancer Institute, Cairo University, Kasr El-Aini Road, Cairo, 11796, Egypt.

View Article

Download full-text PDF

Source
http://journals.sagepub.com/doi/10.1177/1758834017711380
Publisher Site
http://dx.doi.org/10.1177/1758834017711380DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5502951PMC
July 2017

Identification of frequent somatic mutations in inflammatory breast cancer.

Breast Cancer Res Treat 2017 Jun 27;163(2):263-272. Epub 2017 Feb 27.

Section of Translational Breast Cancer Research, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 1354, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-017-4165-0DOI Listing
June 2017

Early clinical development of epidermal growth factor receptor targeted therapy in breast cancer.

Expert Opin Investig Drugs 2017 Apr 8;26(4):463-479. Epub 2017 Mar 8.

a Section of Translational Breast Cancer Research, Department of Breast Medical Oncology , The University of Texas MD Anderson Cancer Center , Houston , TX , USA.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/13543784.2017.1
Publisher Site
http://dx.doi.org/10.1080/13543784.2017.1299707DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5826640PMC
April 2017

Reply to 'Comment on 'Nomogram to predict pathologic complete response in HER2-positive breast cancer treated with neoadjuvant systemic therapy''.

Br J Cancer 2017 04 14;116(8):e11. Epub 2017 Mar 14.

Department of Breast Medical Oncology, Section of Translational Breast Cancer Research, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/bjc.2017.61DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5396116PMC
April 2017

Inflammatory breast cancer: a proposed conceptual shift in the UICC-AJCC TNM staging system.

Lancet Oncol 2017 04;18(4):e228-e232

Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(17)30192-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6140765PMC
April 2017

A target of potential RELAvance in inflammatory breast cancer.

Oncotarget 2017 04;8(16):25835-25836

Department of Breast Medical Oncology, Section of Translational Breast Cancer Research, and The Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.17109DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5432219PMC
April 2017

Nomogram to predict pathologic complete response in HER2-positive breast cancer treated with neoadjuvant systemic therapy.

Br J Cancer 2017 Feb 12;116(4):509-514. Epub 2017 Jan 12.

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/bjc.2016.444DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5318977PMC
February 2017

Mesenchymal stem cells and macrophages interact through IL-6 to promote inflammatory breast cancer in pre-clinical models.

Oncotarget 2016 Dec;7(50):82482-82492

MD Anderson Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.12694DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5347707PMC
December 2016

Impact of androgen receptor expression in fluoxymesterone-treated estrogen receptor-positive metastatic breast cancer refractory to contemporary hormonal therapy.

Breast Cancer Res Treat 2016 11 23;160(1):101-109. Epub 2016 Sep 23.

Section of Translational Breast Cancer Research, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1354, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-016-3986-6DOI Listing
November 2016

Impact of clinical trial on survival outcomes.

Breast Cancer Res Treat 2016 Sep 16;159(2):273-81. Epub 2016 Aug 16.

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030-4009, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-016-3942-5DOI Listing
September 2016

miR-141-Mediated Regulation of Brain Metastasis From Breast Cancer.

J Natl Cancer Inst 2016 08 13;108(8). Epub 2016 Apr 13.

Affiliation of authors: Departments of Experimental Radiation Oncology (BGD, LLa, PD, RAL, ARW, WX, DLS, LLi), Hematopathology (SA, JMR), Experimental Therapeutics (KC, CI, GAC), Pathology (LH, SK), Biostatistics (CW, WW), Radiation Oncology (AB, PKA, TAB, WAW), and Breast Medical Oncology (NTU), The University of Texas MD Anderson Cancer Center, Houston, TX; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX (XHZ); Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX (BGD, LLa, SA, LH, RAL, ARW, WX, DLS, LLi, SK, TAB, NTU, JMR, WAW).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djw026DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5017951PMC
August 2016

MiR-33a Decreases High-Density Lipoprotein-Induced Radiation Sensitivity in Breast Cancer.

Int J Radiat Oncol Biol Phys 2016 06 22;95(2):791-9. Epub 2016 Jan 22.

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2016.01.025DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4851902PMC
June 2016

Landscape of somatic mutations in 560 breast cancer whole-genome sequences.

Nature 2016 06 2;534(7605):47-54. Epub 2016 May 2.

Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nature17676DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4910866PMC
June 2016

Neoadjuvant nab-paclitaxel in the treatment of breast cancer.

Breast Cancer Res Treat 2016 Apr 12;156(3):427-440. Epub 2016 Apr 12.

University of Florida Health Cancer Center at Orlando Health, 1400 South Orange Avenue, Orlando, FL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-016-3778-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4837202PMC
April 2016

Epidemiological risk factors associated with inflammatory breast cancer subtypes.

Cancer Causes Control 2016 Mar 21;27(3):359-66. Epub 2016 Jan 21.

Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, 1155 Pressler St., Unit 1360, P.O. Box 301439, Houston, TX, 77230, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10552-015-0712-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4778706PMC
March 2016

High HER2/Centromeric Probe for Chromosome 17 Fluorescence In Situ Hybridization Ratio Predicts Pathologic Complete Response and Survival Outcome in Patients Receiving Neoadjuvant Systemic Therapy With Trastuzumab for HER2-Overexpressing Locally Advanced Breast Cancer.

Oncologist 2016 Jan 9;21(1):21-7. Epub 2015 Dec 9.

Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2015-0101DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4709200PMC
January 2016

MEK Inhibitor Selumetinib (AZD6244; ARRY-142886) Prevents Lung Metastasis in a Triple-Negative Breast Cancer Xenograft Model.

Mol Cancer Ther 2015 Dec 17;14(12):2773-81. Epub 2015 Sep 17.

Section of Translational Breast Cancer Research, Houston, Texas. Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-15-0243DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4674314PMC
December 2015

Antitumor Activity of KW-2450 against Triple-Negative Breast Cancer by Inhibiting Aurora A and B Kinases.

Mol Cancer Ther 2015 Dec 6;14(12):2687-99. Epub 2015 Oct 6.

Section of Translational Breast Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-15-0096DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4674309PMC
December 2015

Comprehensive Two- and Three-Dimensional RNAi Screening Identifies PI3K Inhibition as a Complement to MEK Inhibitor AS703026 for Combination Treatment of Triple-Negative Breast Cancer.

J Cancer 2015 28;6(12):1306-19. Epub 2015 Oct 28.

2. Department of Bioinformatics and Computational Biology - Unit 1410, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, 77030, USA;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7150/jca.13266DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4643087PMC
December 2015

Circulating Tumor Cells and Recurrence After Primary Systemic Therapy in Stage III Inflammatory Breast Cancer.

J Natl Cancer Inst 2015 Nov 14;107(11). Epub 2015 Sep 14.

Departments of Surgical Oncology (CSH, MK, BAL, HMK, SD, AEA, AL), Surgical Pathology (SK), Breast Medical Oncology (VV, NTU), and Biostatistics (LY, SX), The University of Texas MD Anderson Cancer Center, Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djv250DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4849361PMC
November 2015